scholarly article | Q13442814 |
P356 | DOI | 10.1007/S10620-010-1408-X |
P698 | PubMed publication ID | 20848200 |
P50 | author | Edoardo G. Giannini | Q41633423 |
P2093 | author name string | Vincenzo Savarino | |
Antonino Picciotto | |||
Monica Basso | |||
P2860 | cites work | Persistent infection of hepatitis C virus in the elderly: a clinical and quantitative pathological study of autopsy cases | Q42994839 |
Chronic liver disease related to hepatitis C virus: age of patients seems to be a determinant of severity independently of viral genotype. | Q42998094 | ||
The effect of age on response to therapy with peginterferon alpha plus ribavirin in a cohort of patients with chronic HCV hepatitis including subjects older than 65 yr. | Q43036906 | ||
Clinical outcomes after transfusion-associated hepatitis C. | Q44746801 | ||
Hepatitis C: Should antiviral therapy be offered to elderly patients? | Q50561889 | ||
Efficacy of peginterferon-alpha-2b plus ribavirin in patients aged 65 years and older with chronic hepatitis C. | Q50562605 | ||
Are elderly patients poor candidates for pegylated interferon plus ribavirin in the treatment of chronic hepatitis C? | Q50576728 | ||
Epidemiology of hepatitis C virus infection | Q22305500 | ||
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection | Q27860901 | ||
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial | Q27860949 | ||
An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group | Q29614898 | ||
Histological grading and staging of chronic hepatitis | Q29619625 | ||
The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 | ||
Elderly patients are at greater risk of cytopenia during antiviral therapy for hepatitis C. | Q33372766 | ||
Hepatitis C in 6,865 patients 65 yr or older: a severe and neglected curable disease? | Q34537738 | ||
Monitoring of viral levels during therapy of hepatitis C. | Q34984089 | ||
Appendix: The National Institutes of Health Consensus Development Conference Management of Hepatitis C 2002. | Q35105731 | ||
Ten year incidence of HCV infection in northern Italy and frequency of spontaneous viral clearance. | Q35595775 | ||
Practical use of hepatitis C virus kinetics monitoring in the treatment of chronic hepatitis C. | Q36980745 | ||
The changing epidemiology of hepatitis C virus infection in Europe | Q37006042 | ||
Efficacy and safety of pegylated interferon combined with ribavirin for the treatment of older patients with chronic hepatitis C. | Q38376150 | ||
Projecting future complications of chronic hepatitis C in the United States | Q40594872 | ||
Hepatitis C virus infection and related chronic liver disease in a resident elderly population: the Silea Study | Q42990661 | ||
P433 | issue | 11 | |
P921 | main subject | ribavirin | Q421862 |
P304 | page(s) | 3193-3199 | |
P577 | publication date | 2010-09-18 | |
P1433 | published in | Digestive Diseases and Sciences | Q15716711 |
P1476 | title | Predictive factors for response to peginterferon-alpha and ribavirin treatment of chronic HCV infection in patients aged 65 years and more. | |
P478 | volume | 55 |
Q37879193 | Antiviral therapy: why does it fail in HCV-related chronic hepatitis? |
Q50550604 | Efficacy and safety of ribavirin plus pegylated interferon alfa in geriatric patients with chronic hepatitis C. |
Q38160178 | Predictors for dose reduction of antiviral therapy in older patients infected with hepatitis C virus: a meta-regression analysis |
Q40707649 | Response to peginterferon-alpha 2b and ribavirin in Japanese patients with chronic hepatitis C genotype 1. |
Q34190390 | The effect of pegylated interferon-alpha2b and ribavirin combination therapy for chronic hepatitis C infection in elderly patients |
Q33635003 | Treatment of hepatitis C virus infection and associated vascular complications: a literature review |
Search more.